Bio-Techne Corp
NASDAQ:TECH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
62.12
84.15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Bio-Techne Corp
Wall Street
Price Targets
TECH Price Targets Summary
Bio-Techne Corp
According to Wall Street analysts, the average 1-year price target for
TECH
is 87.11 USD
with a low forecast of 75.75 USD and a high forecast of 99.75 USD.
TECH Last Price Targets
Bio-Techne Corp
The latest public price target was made on Oct 31, 2024 by
Catherine Schulte
from
Robert W. Baird
,
who expects
TECH
stock to
rise by 15%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Catherine Schulte
Robert W. Baird
|
84
USD
Upside 15% |
1 month ago
Oct 31, 2024
|
Bio-Techne Corp. (TECH) PT Raised to $84 at Baird
StreetInsider
|
Paul Knight
KeyBanc
|
80
USD
Upside 9% |
1 month ago
Oct 30, 2024
|
KeyBanc Reiterates Overweight Rating on Bio-Techne Corp. (TECH)
StreetInsider
|
Sung Ji Nam
Scotiabank
|
83
USD
Upside 13% |
4 months ago
Aug 16, 2024
|
Scotiabank Reiterates Sector Outperform Rating on Bio-Techne Corp. (TECH)
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TECH's stock price target?
Price Target
87.11
USD
According to Wall Street analysts, the average 1-year price target for
TECH
is 87.11 USD
with a low forecast of 75.75 USD and a high forecast of 99.75 USD.
What is Bio-Techne Corp's Revenue forecast?
Projected CAGR
9%
For the last 8 years the
compound annual growth rate for
Bio-Techne Corp's revenue is
11%.
The projected
CAGR
for the next 3 years is
9%.
What is Bio-Techne Corp's Operating Income forecast?
Projected CAGR
27%
For the last 8 years the
compound annual growth rate for
Bio-Techne Corp's operating income is
6%.
The projected
CAGR
for the next 3 years is
27%.
What is Bio-Techne Corp's Net Income forecast?
Projected CAGR
35%
For the last 8 years the
compound annual growth rate for
Bio-Techne Corp's net income is
6%.
The projected
CAGR
for the next 3 years is
35%.
You don't have any saved screeners yet
